FindTrial
Sign In

Evaluation of Lymph Node Metastasis and Recurrence Risk in T1 Colorectal Cancer Based on a Multimodal Imaging-Pathology Fusion Model

Evaluation of Lymph Node Metastasis and Recurrence Risk in T1 Colorectal Cancer Based on a Multimodal Imaging-Pathology Fusion Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118989
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-28
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Model Training group:None

Sponsors

The Third Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Primary T1 colorectal cancer confirmed by histopathology; 2. No anticancer treatment was administered before lesion removal; 3. Available contrast-enhanced CT images in arterial and venous phases, covering the entire colon and rectum; 4. Tissue histopathology slides are available, and high-risk factors can be assessed.

Exclusion criteria

Exclusion criteria: 1. Concurrent presence of other malignant tumors; 2. Clinically suspected familial adenomatous polyposis; 3. Enhanced CT images cannot delineate the lesion boundaries due to artifacts, intussusception, or unclear separation of intestinal contents; 4. The interval between preoperative enhanced CT examination and tumor resection exceeds one month.

Design outcomes

Primary

MeasureTime frame
Postoperative pathological confirmation of LNM status;—

Countries

China

Contacts

Public ContactSidong Xie

The Third Affiliated Hospital Sun Yat-sen University

xiesdong@mail.sysu.edu.cn+86 20 85253108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026